US regulators’ effectiveness in monitoring the consumer health market for fraudulent COVID-19-related claims or for unsafe products in high demand because of the pandemic could be shown by two measures: warning letters noting the coronavirus have slowed to a drip while recalls continue climbing for products already identified in warnings.
Warnings published on 1 October to two dietary supplement marketers making violative claims for products to prevent or treat COVID-19 infections were the first for the Food and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?